Anyone may join the Health Network — this is an open-information resource. Local information circulated will link either directly or indirectly to health. Contact Vicky Attwood for more information.
We are trusted by a growing base of clients in pharma, medtech and healthcare services. Leveraging our proprietary data and macroeconomic forecasting capabilities, we have been able to offer robust analysis of the demand for specific therapies at a subnational level within emerging markets. The client wanted us to quantify the economic burden of disease in specific emerging and developed countries in order to fully understand the scale of the problem.
Our in-house team of country analysts and skilled macroeconomists developed methodologically solid estimates and forecasts across a variety of markets. We developed a model estimating direct healthcare and non-healthcare related costs, as well as the impact of the illness on economic productivity.
The results were incorporated in a white paper outlining the major challenges and opportunities in addressing the problem. This was released on the web for public consumption, and benefited from The Economist Intelligence Unit's editorial trademark.
It asked us to undertake high-level discussions with government policymakers and advisory boards on development directions. We conducted in-depth concept tests with decision-makers and clinicians on product attractiveness and viability, as well as trade-off analysis to gauge the importance of price versus features.
This enabled our client to gain insights on government initiatives that will affect product development, allowing it to adapt product design to local demand and to launch its product at the most effective price point and positioning.
Close Value consulting Our client, a leading pharmaceutical company with a portfolio of drugs in chronic pain management, wanted us to review regulatory regimes governing how the cost of sick leave is shared in 17 European countries and to provide an assessment of quantitative information on the cost of chronic pain.
We undertook a review of regulatory systems of the countries in scope and developed a data visualisation tool for the client to understand how the burden of sick leave is shared between the state, the employer and the employee. Our data provided insights on relative market opportunity for the strategic planning team, and enabled it to engage stakeholders and payers in productivity and healthcare conversations.
We prepared data visualisation and comparisons for report country pages and liaised with journalists at The Economist to help to make the report more accessible to policymakers and the general public.
The final product was a series of externally facing co-branded research and white papers, created to facilitate thought leadership and debate. They also wanted to map the findings to the predicted domestic government contributions to financing the cost of these vaccines and to forecast the cost-funding gap from Our in-house modelling expertise, partnered with key academic institutions, enabled us to prepare vaccine cost forecasts.
Finally, we drew upon our data visualisation skill to house the data in a user-friendly spreadsheet model with country-specific drop-down menus and tabs showing different data aspects, which enabled the client to use the output for fundraising and planning purposes.
Close Strategic advisory We have worked for a number of pharma and medtech clients to identify the key innovations in the healthcare sector and evaluate opportunities for greenfield investment and future business expansion. We design global studies, provide recommendations and moderate workshops and brainstorming sessions at a Board level.
Close Value consulting Payors like the NHS are increasingly demanding healthcare solutions rather than product offerings.
This study illustrates work that we can do with suppliers to help them engage constructively with payors. Our client needed to understand the market potential, demand and case mix for renal replacement therapy and how it will evolve in the next five years.
The client uses the interactive model to plan capacity and to assess the potential impact of service configuration changes to the flow of patients, as well as to allocate budget. We conducted in-depth interviews with opinion leaders to gauge views of demand dynamics and technology movements, and produced an activity-based gap analysis of a representative sample size of mid- to low-workload lab users to identify penetration and adoption opportunities.We have produced a series of factsheets about data uses and the national data opt-out, which is presented to the public as 'Your Data Matters to the NHS'.
Meeting the general equality duty Title: business planning Which of the three aims is this information and repatriate work from other NHS and private providers. In order to gain a larger share of a shrinking acute market, particular focus will and longer-term, business planning process it is important to ensure.
NHS website. NHS website (formerly called NHS Choices) is the primary public facing website of the urbanagricultureinitiative.com pages include directories of local health services (a Directory of Services), information on a wide range of conditions and treatments and accessible public health information.
The NHSmail service is available anywhere, over either the NHS N3 network or the open internet. The service can be viewed through a free web based client or alternatively pharmacies can choose to connect the service to a local email client they have purchased, for example Microsoft Outlook.
Skype for Business is now available! Skype for Business can be used to enable your teams to collaborate in new ways. Instant Messaging and Presence is now available to all NHSmail users.
Graveyards are full of indispensable people, it has been said. Life must go on, even after the irreplaceable have departed. So businesses and organisations should be ready to continue when.